HUSCOKE HLDGS (00704) requests the Listing Review Committee to review the decision of the Listing Committee.
Junhe Holdings (00704) announces that, after internal discussions and consultations with professional advisors, the company submitted a written request to the Listing Review Committee on December 18, 2025, seeking further and final review by the Listing Review Committee in accordance with Chapter 2B of the Listing Rules. The Board hereby notifies shareholders and potential investors of this announcement.
HUSCOKE HLDGS (00704) issues announcement, the Board of Directors hereby notifies the company's shareholders and potential investors that, after internal discussions and consultations with professional advisors, the company submitted a written request to the Listing Review Committee on December 18, 2025, seeking further and final review of the Listing Committee's decision in accordance with Chapter 2B of the Listing Rules.
We would like to remind our shareholders and potential investors that there is uncertainty in the outcome of the review application. The company will issue timely announcements for any significant developments.
Related Articles
China Feihe (06186) spent HK$12.3269 million on December 18 to repurchase 304,600 shares.
New stock news | With a compound annual growth rate of 2500%, Bitar Technology aims to become the "first stock for Hong Kong GPU" with over 1.2 billion orders in hand.
Shanghai Fosun Pharmaceutical (600196.SH) Signs Cooperation and Option Agreement with Clavis Bio.
China Feihe (06186) spent HK$12.3269 million on December 18 to repurchase 304,600 shares.
New stock news | With a compound annual growth rate of 2500%, Bitar Technology aims to become the "first stock for Hong Kong GPU" with over 1.2 billion orders in hand.
Shanghai Fosun Pharmaceutical (600196.SH) Signs Cooperation and Option Agreement with Clavis Bio.
